Global Soliris Market Size, Share, Trends and Forecast 2022-2030

Description

Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.
Industry Insights

Due to the COVID-19 pandemic, the global Soliris market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Soliris market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Soliris landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Prior to COVID-19, the China market for Soliris was anticipated to grow from US$ 43.15 million in 2020 to US$ 105.67 million by 2026; it is expected to grow at a CAGR of 14.86% during 2021-2026, whereas post-COVID-19 scenario, the market for Soliris is projected to grow from US$ 40.9 million in 2020 (a change by ~-6.4% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ 100.58 million by 2026; it is expected to grow at a CAGR of 14.75% during 2021-2026. The solicitation of proposals by the governments and public-private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Soliris market.The classification of Soliris includes Plasma Exchange and Plasma Infusion, and the proportion of Plasma Exchange in 2019 is about 76.36%, and the proportion is in increasing trend from 2013 to 2018.

Soliris is widely used for patients of PNH, aHUS and other. The most proportion of Soliris is used for patients of PNH, and the proportion in 2019 is 66.85%.

This report focuses on Soliris volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Soliris market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Japan and China, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Soliris market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Plasma Exchange

Plasma Infusion

Segment by Application

PNH

aHUS

Other

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Alexion

TABLE OF CONTENT

1 Soliris Market Overview
1.1 Product Overview and Scope of Soliris

1.2 Soliris Segment by Type

1.2.1 Global Soliris Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Plasma Exchange

1.2.3 Plasma Infusion

1.3 Soliris Segment by Application

1.3.1 Global Soliris Sales Comparison by Application: (2022-2028)

1.3.2 PNH

1.3.3 aHUS

1.3.4 Other

1.4 Global Soliris Market Size Estimates and Forecasts

1.4.1 Global Soliris Revenue 2017-2028

1.4.2 Global Soliris Sales 2017-2028

1.4.3 Soliris Market Size by Region: 2017 Versus 2021 Versus 2028

2 Soliris Market Competition by Manufacturers

2.1 Global Soliris Sales Market Share by Manufacturers (2017-2022)

2.2 Global Soliris Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Soliris Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Soliris Manufacturing Sites, Area Served, Product Type

2.5 Soliris Market Competitive Situation and Trends

2.5.1 Soliris Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Soliris Players Market Share by Revenue

2.5.3 Global Soliris Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Soliris Retrospective Market Scenario by Region

3.1 Global Soliris Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Soliris Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Soliris Market Facts & Figures by Country

3.3.1 North America Soliris Sales by Country

3.3.2 North America Soliris Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Soliris Market Facts & Figures by Country

3.4.1 Europe Soliris Sales by Country

3.4.2 Europe Soliris Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Soliris Market Facts & Figures by Region

3.5.1 Asia Pacific Soliris Sales by Region

3.5.2 Asia Pacific Soliris Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Soliris Market Facts & Figures by Country

3.6.1 Latin America Soliris Sales by Country

3.6.2 Latin America Soliris Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Soliris Market Facts & Figures by Country

3.7.1 Middle East and Africa Soliris Sales by Country

3.7.2 Middle East and Africa Soliris Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Soliris Historic Market Analysis by Type

4.1 Global Soliris Sales Market Share by Type (2017-2022)

4.2 Global Soliris Revenue Market Share by Type (2017-2022)

4.3 Global Soliris Price by Type (2017-2022)

5 Global Soliris Historic Market Analysis by Application

5.1 Global Soliris Sales Market Share by Application (2017-2022)

5.2 Global Soliris Revenue Market Share by Application (2017-2022)

5.3 Global Soliris Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Alexion

6.1.1 Alexion Corporation Information

6.1.2 Alexion Description and Business Overview

6.1.3 Alexion Soliris Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Alexion Soliris Product Portfolio

6.1.5 Alexion Recent Developments/Updates

7 Soliris Manufacturing Cost Analysis

7.1 Soliris Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Soliris

7.4 Soliris Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Soliris Distributors List

8.3 Soliris Customers

9 Soliris Market Dynamics

9.1 Soliris Industry Trends

9.2 Soliris Market Drivers

9.3 Soliris Market Challenges

9.4 Soliris Market Restraints

10 Global Market Forecast

10.1 Soliris Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Soliris by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Soliris by Type (2023-2028)

10.2 Soliris Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Soliris by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Soliris by Application (2023-2028)

10.3 Soliris Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Soliris by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Soliris by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample